Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001;5(2):S1-5.
doi: 10.1186/cc1332.

Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology

Affiliations

Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology

J L Vincent. Crit Care. 2001.

Abstract

Severe sepsis, defined as sepsis associated with acute organ dysfunction, results from a generalized inflammatory and procoagulant host response to infection. Coagulopathy in severe sepsis is commonly associated with multiple organ dysfunction, and often results in death. The molecule that is central to these effects is thrombin, although it may also have anticoagulant and antithrombotic effects through the activation of Protein C and induction of prostacyclin. In recent years, it has been recognized that chemicals produced by endothelial cells play a key role in the pathogenesis of sepsis. Thrombomodulin on endothelial cells coverts Protein C to Activated Protein C, which has important antithrombotic, profibrinolytic and anti-inflammatory properties. A number of studies have shown that Protein C levels are reduced in patients with severe infection, or even in inflammatory states without infection. Because coagulopathy is associated with high mortality rates, and animal studies have indicated that therapeutic intervention may result in improved outcomes, it was rational to initiate clinical studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Central role of thrombin in acute sepsis. PAF, platelet-activating factor; PGI2, prostacyclin; PMN, polymorphonuclear leukocyte.
Figure 2
Figure 2
Experimental model of sepsis in volunteers: Effect of small doses of endotoxin (lipopolysaccharide [LPS]) or TNF on the fibrinolysis system. PAP, plasmin-antiplasmin complex; t-PA, tissue plasminogen activator.
Figure 3
Figure 3
Procoagulant and anticoagulant substances that are expressed/released by endothelial cells. AT, antithrombin; NO, nitric oxide; PGI2, prostacyclin; TFPI, TF pathway inhibitor.
Figure 4
Figure 4
Protein C levels (% of normal) in patients with meningococcaemia. Adapted from Powars et al [9].
Figure 5
Figure 5
TNF-α levels (normal range <15 pg/ml) and Protein C activity (normal range 60-140%) in malaria. Adapted from Hemmer et al [10].
Figure 6
Figure 6
Coagulation abnormalities in pneumonia (Pneu) and acute respiratory distress syndrome (ARDS; n = 222). SPV, spontaneous ventilation; MV, mechanical ventilation. Adapted from Günther et al [17].

References

    1. Hau T, Simmons RL. Heparin in the treatment of experimental peritonitis. Ann Surg. 1978;187:294–298. - PMC - PubMed
    1. Chalkiadakis G, Kostakis A, Karayannacos PE, Giamarellou H, Dontas I, Sakellariou I, Skalkeas GD. The effect of heparin upon fibrinopurulent peritonitis in rats. Surg Gynecol Obstet. 1983;157:257–260. - PubMed
    1. Emerson TE Jr, Fournel MA, Redens TB, Taylor FB Jr. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. Am J Med. 1989;87(suppl B):27S–33S. doi: 10.1016/0002-9343(89)80528-5. - DOI - PubMed
    1. Triantaphyllopoulos DC. Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost. 1984;51:232–235. - PubMed
    1. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127–134. - PubMed

MeSH terms